QTc Information in Human Prescription Drug and Biological Product Labeling: Guidance for Industry
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
December 3, 2025
December 2, 2025
84e1bfb1-3a7d-4f4f-ad99-9da85ee92408
Related Documents
Adjusting for Covariates in Randomized Clinical Trials for Drugs and Biological Products
Guidance DocumentMay 26, 2023Center for Drug Evaluation and Research
Pediatric Information Incorporated Into Human Prescription Drug and Biological Products Labeling Good Review Practice
Guidance DocumentMarch 28, 2019Center for Drug Evaluation and Research
Cross Labeling Oncology Drugs in Combination Regimens
Guidance DocumentNovember 2, 2022Center for Drug Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Subscribe to our newsletter
Get the latest updates and insights delivered to your inbox